Chris Wigley is the CEO of Genomics England, which exists to push insights from cutting edge genomics data analytics into routine medical care. As the national steward of 40 petabytes of human genome data from 100,000 volunteers, and a unique partnership with the NHS, Genomics England’s goal is to improve patient outcomes while lowering the cost of healthcare provision. Through the COVID crisis Chris was seconded as Senior Responsible Officer for Data to NHSX, and Genomics England launched a major research programme into the genomic drivers of severity of response to COVID.
Chris was previously COO at QuantumBlack, a bespoke Machine Learning and AI technology company, and a Partner at McKinsey working on technology strategy topics. He is a trustee of the New Entrepreneurs Foundation, and on the Advisory Board of deep-tech VC Entrepreneur First. He previously worked for the UK Foreign Office, establishing and leading analytical work at the Counter Terrorism Policy Department to counter chemical, biological and nuclear terror threats. Chris lives in London with his wife Tara and their three children.
An unruly pandemic has forever changed the face of healthcare and the technologies that help run it. So now we ask the question: what’s next for the health and wellbeing industry? Join Dr. Jack...
- Kevin Cahill - Former CEO of Comic Relief and Founder The Talent Fund Charity
- Chris Wigley - CEO - Genomics England
- Ramani Moonesinghe - National Clinical Director for Critical and Perioperative Care, NHS England and NHS Improvement
- Dr Jack Kreindler - Founder & Medical Director - Centre for Health and Human Performance (Moderator)